Capricor Therapeutics (CAPR) Current Deferred Revenue (2014 - 2026)
Capricor Therapeutics (CAPR) reported Current Deferred Revenue of $12 million for Q2 2026, unchanged from $12 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Capricor Therapeutics (CAPR) Current Deferred Revenue (2014 - 2026) Analysis & Trends
Dating back to Q1 2014, Capricor Therapeutics' Current Deferred Revenue record includes 31 quarters.
- Current Deferred Revenue has a three-year compound annual growth rate of -12.6% (FY2022 to FY2025).
- By year, Current Deferred Revenue came in at $12 million in FY2024 (-50.6%), $24.27 million in FY2023 (+35.0%) and $17.98 million in FY2022.
- Five-year quarterly Current Deferred Revenue spans a low of $12 million in Q4 2024 and a high of $31.01 million in Q1 2023.
- The high point for year-over-year Current Deferred Revenue in five years was Q2 2023 (growth of 86.2%); the low point was Q4 2024 (a decline of 50.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $12 million (Q1 2026), $12 million (Q4 2025) and $12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Capricor Therapeutics | 515.69 Mn | -516.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.00 Mn |
| Jun 30, 2026 | 12.00 Mn |
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 12.00 Mn |
| Sep 30, 2025 | 12.00 Mn |
| Jun 30, 2025 | 12.00 Mn |
| Mar 31, 2025 | 12.00 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | 13.13 Mn |
| Jun 30, 2024 | 15.39 Mn |
| Mar 31, 2024 | 19.36 Mn |
| Dec 31, 2023 | 24.27 Mn |
| Sep 30, 2023 | 25.41 Mn |
| Jun 30, 2023 | 29.31 Mn |
| Mar 31, 2023 | 31.01 Mn |
| Dec 31, 2022 | 17.98 Mn |
| Sep 30, 2022 | 18.60 Mn |
| Jun 30, 2022 | 15.75 Mn |
| Mar 31, 2022 | 30.00 Mn |
| Mar 31, 2017 | 683,592.00 |
API Access
Capricor Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CAPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CAPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CAPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();